Ethos Discovery acts as an incubator for Scientific Innovations addressing unmet diagnostic and therapeutic needs.
Our scientific studies are aligned with the innovation platforms of a variety of academic and other research institutions. We embrace the established scientific model of Comparative Oncology in our approach, evaluating novel therapeutic treatments and diagnostics in pets with naturally-occurring medical conditions.
About Us
Donate
Help change the future for pets (and humans) with complex medical problems. 100% of your donation will go towards supporting our research.
Learn more & Donate Today
Our Programs
Our scientific strategy focuses on identifying areas of unmet need through the optics of clinical teams within Ethos Veterinary Health. These hospitals provide access to clinical trials to patients with naturally occurring disease.
Our Studies
Our Team
The leadership team at Ethos Discovery aligns the identified, unmet needs of clinical veterinary teams with academic and institutional nonprofit and commercial collaborators around the world.
Leadership TeamLatest Posts
View All-
Ethos Discovery vs Canine Hemangiosarcoma
February 12, 2021Ethos-PUSH will serve as the largest collection of canine hemangiosarcoma biospecimens in the world. These biospecimens will be made available to independent collaborators with the goal of further understanding the genomics, epigenomics, and biology of hemangiosarcoma.
Read Article -
Diagnosis, Treatment and Future Study Direction in Dogs with Intestinal Dysbiosis
September 11, 2020A patient with intestinal dysbiosis can have decreased appetite, diarrhea, vomiting, or a variety of other clinical signs.
Read Article -
Hemangiosarcoma – Developing New Treatment Options
August 12, 2020Ethos Discovery hopes to improve the outcome for dogs with hemangiosarcoma and take a similar path as to that of human childhood leukemia, which through significant research efforts went from a commonly fatal disease to a commonly cured disease.
Read Article
Latest News
WSAVA-Supported Oncology Manuscript Highlights Benefits to Humans and Dogs of Collaboration between the Pharmaceutical and Biotech Industries in Drug Development
June 9, 2020Press Information Date of issue: 5 June 2020 A workshop on Comparative Oncology, hosted by the World Small Animal Veterinary Association (WSAVA’s) One Health Committee (WSAVA OHC) during its 2019 World Congress in Toronto, has resulted in the publication of a manuscript that highlights the value of closer commercial relationships between the human and animal
Read Article